CTRI/2009/091/000782已完成2 期
A Multicenter, Randomized, Investigator-Blind, Parallel Group, Three Arm Pilot Study To Evaluate The Safety And Efficacy of Tazarotene Microsphere Cream 0.09% as compared To Differin (Adapalene) Gel 0.1% And Tazorac (Tazarotene) Cream 0.1% In Once Daily Treatment Of Patients With Moderate Facial Acne Vulgaris For 12 Weeks
Promius Pharma0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female patients aged 12 to 50 years, with a diagnosis of moderate facial acne vulgaris.
- •2.Facial inflammatory lesion count >20 and < 50 (both inclusive), non-inflammatory lesions count of atleast 20-100 and IGA score = 3.
排除标准
- •Patients with 2 nodulocystic lesions, prior topical acne treatment or systemic anti-inflammatory agents in past 14 days, Systemic corticosteroids, antibacterials, immunosuppressant drugs or abradent facial procedures in the past 30 days, patients with other concurrent facial skin disease and patients who are photosensitive or who are likely to engage in activities that involve excessive or prolonged exposure to sunlight.
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the efficacy and safety of a new formulation (Cream) for the treatment of psoriasis vulgaris in adults as compared to a product already availible on the market and placebo.EUCTR2018-001970-66-CZMC2 Therapeutics Ltd.490
进行中（未招募）
1 期
Evaluation of the efficacy and safety of a new formulation (Cream) for the treatment of psoriasis vulgaris in adults as compared to a product already availible on the market and placebo.EUCTR2018-001970-66-DEDrug Delivery SolutionsLtd (Part of MC2 Therapeutics)490
招募中
2 期
A clinical trial to know the abnormal respone of cortisol secretion following topical clobetasol propionate cream application in patients with psoriasisCTRI/2012/03/002520Dr Reddys Laboratories90
进行中（未招募）
1 期
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating PolyradiculoneuropathyChronic inflammatory demyelinating polyradiculoneuropathy (CIDP)MedDRA version: 21.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-002411-17-BECB Biopharma SR34
已完成
2 期
A Multicenter, Randomized, Subject-Blind, Investigator-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)10012303NL-OMON48909CB Biopharma SPR5